UbcH10 expression on thyroid fine‐needle aspirates
- 11 June 2010
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 118 (3) , 157-165
Abstract
BACKGROUND: Thyroid fine‐needle aspiration (FNA) samples belonging to the follicular neoplasm/suspicious for malignancy classes are controversial. The authors identified UbcH10 as a marker useful in the diagnosis of several neoplasms, including thyroid cancer. Here, analysis of UbcH10 expression by quantitative reverse transcriptase polymerase chain reaction (RT‐PCR) and immunohistochemistry was applied to FNAs.METHODS: A series of 84 follicular neoplasm/suspicious for malignancy FNAs with histological follow‐up (30 malignant) was prospectively collected. UbcH10 immunostaining was performed on cell blocks and compared with that of the proliferation marker Ki‐67. At the mRNA level, UbcH10 was compared with CCND2 and PCSK2 expression, these latter being the best performing components of the previously reported 3‐gene assay; to determine the diagnostic accuracy, the area under the curve (AUC) of the receiver operating characteristic (ROC) curve for each gene individually and in combination was evaluated.RESULTS: UbcH10 and Ki‐67 shared a similar pattern; although UbcH10 expression was higher in malignant than in benign lesions (P < .001), staining was sporadic, and the cutoff value derived by the ROC analysis was too low (1.25%) for routine application. Conversely, UbcH10 expression assessment by quantitative RT‐PCR was effective. UbcH10 mRNA levels associated with malignant histology were significantly higher than those associated with benign histology (P = .02). The AUC was 0.74 for UbcH10, 0.81 for CCDN2, 0.62 for PCSK2, and 0.84 for UbcH10 and CCND2 combination.CONCLUSIONS: UbcH10 quantitative RT‐PCR analysis, rather than immunohistochemistry, is useful to increase the detection of malignancy in thyroid FNAs. UbcH10 may be added as a panel component in quantitative RT‐PCR–based assays. Cancer (Cancer Cytopathol) 2010. © 2010 American Cancer Society.Keywords
This publication has 28 references indexed in Scilit:
- Does the 3‐gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?Cancer, 2008
- Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science ConferenceDiagnostic Cytopathology, 2008
- Diagnostic and Prognostic Value of Cell‐cycle Regulatory Genes in Malignant Thyroid NeoplasmsWorld Journal of Surgery, 2006
- Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical applicationEndocrine-Related Cancer, 2005
- BRAF mutation in thyroid cancerEndocrine-Related Cancer, 2005
- Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene CombinationThe Journal of Clinical Endocrinology & Metabolism, 2005
- The heart of the cycleNature, 2004
- Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytologyDiagnostic Cytopathology, 2002
- Analysis of ret/PTC Gene Rearrangements Refines the Fine Needle Aspiration Diagnosis of Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2001
- Management of a Solitary Thyroid NoduleNew England Journal of Medicine, 1993